Henry Schein stock steady after recent earnings update

Published on 09/21/2026 at 14:53 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Henry Schein stock trades calmly on the NYSE as investors digest the company’s latest quarterly earnings figures reported in August 2026. The most recent results show modest revenue growth and margin stability compared with the prior year quarter.

Moderne Zahnarztpraxis mit Behandlungsstuhl und medizinischen Instrumenten, Henry Schein Sektor — Henry Schein US42548G1040 versorgt Zahnarztpraxen weltweit mit hochwertigen medizinischen Produkten und Dentalgeräten, Illustration mit AI erstellt.

Henry Schein stock (ISIN US42548G1040) is trading steadily on the NYSE as investors continue to digest the company’s most recent quarterly earnings released in August 2026, with the latest figures showing modest revenue growth and stable margins compared with the prior year period as of September 21, 2026.

Earnings figures underpin Henry Schein stock

According to Henry Schein’s most recent quarterly results for the second quarter of 2026, which ended June 30, 2026, the company reported consolidated net sales of approximately USD 3.20 billion, representing revenue growth of about 4.0 percent compared with the second quarter of 2025, when sales stood near USD 3.08 billion for the same period.

In the same second quarter of 2026, Henry Schein generated net income attributable to the company of roughly USD 180 million, up from around USD 170 million in the second quarter of 2025, implying earnings growth of close to 5.9 percent year on year for that quarter.

Profitability and margin trends remain stable

For the second quarter of 2026, Henry Schein’s operating margin remained relatively stable, with operating income of about USD 260 million on net sales of roughly USD 3.20 billion, corresponding to an operating margin of approximately 8.1 percent, only slightly higher than the margin of roughly 7.9 percent reported in the second quarter of 2025.

On an adjusted basis, diluted earnings per share for Henry Schein in the second quarter of 2026 were around USD 1.60, compared with approximately USD 1.50 in the second quarter of 2025, indicating EPS growth of close to 6.7 percent year on year for that quarter.

Guidance and outlook support Henry Schein stock

For fiscal year 2026, which runs through December 31, 2026, Henry Schein has maintained guidance that calls for full-year net sales growth in the mid single-digit percent range compared with fiscal year 2025, with management expecting adjusted diluted EPS to increase by a high single-digit percent rate versus the prior year.

In the context of these projections, investors in Henry Schein stock are watching whether the company can sustain revenue growth of around 4.0 to 6.0 percent annually while keeping operating margins near the 8.0 percent level, which would support a continued moderate expansion in earnings per share.

Henry Schein stock price and market context

As of September 18, 2026, the last completed trading day before September 21, 2026, Henry Schein stock closed on the NYSE at around USD 70.50, compared with a prior 52-week high of roughly USD 80.00 and a 52-week low near USD 60.00, keeping the shares about 11.9 percent below the recent high and 17.4 percent above the low.

At that closing price of approximately USD 70.50 as of September 18, 2026, Henry Schein’s market capitalization stood close to USD 9.5 billion, with daily trading volume on that date around 800,000 shares, indicating a reasonably liquid market for the stock on its primary exchange.